| Item Type | Name |
|
Concept
|
Graft vs Host Disease
|
|
Academic Article
|
Hematopoietic growth factors after HLA-identical allogeneic bone marrow transplantation in patients treated with methotrexate-containing graft-vs.-host disease prophylaxis.
|
|
Academic Article
|
Immunoablative reduced-intensity stem cell transplantation: potential role of donor Th2 and Tc2 cells.
|
|
Academic Article
|
Nonmyeloablative allogeneic stem cell transplantation: early promise and limitations.
|
|
Academic Article
|
Vulvovaginal chronic graft-versus-host disease with allogeneic hematopoietic stem cell transplantation.
|
|
Academic Article
|
Outcome of allogeneic stem cell transplantation for B cell chronic lymphocytic leukemia.
|
|
Academic Article
|
Host T cells affect donor T cell engraftment and graft-versus-host disease after reduced-intensity hematopoietic stem cell transplantation.
|
|
Academic Article
|
Principles and overview of allogeneic hematopoietic stem cell transplantation.
|
|
Academic Article
|
A randomized, double-blind trial of filgrastim (granulocyte colony-stimulating factor) versus placebo following allogeneic blood stem cell transplantation.
|
|
Academic Article
|
Establishment of early donor engraftment after reduced-intensity allogeneic hematopoietic stem cell transplantation to potentiate the graft-versus-lymphoma effect against refractory lymphomas.
|
|
Academic Article
|
A multicenter pilot evaluation of the National Institutes of Health chronic graft-versus-host disease (cGVHD) therapeutic response measures: feasibility, interrater reliability, and minimum detectable change.
|
|
Academic Article
|
NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on the Epidemiology and Natural History of Relapse following Allogeneic Cell Transplantation.
|
|
Academic Article
|
Targeted pretransplant host lymphocyte depletion prior to T-cell depleted reduced-intensity allogeneic stem cell transplantation.
|
|
Academic Article
|
Prognostic factors of chronic graft-versus-host disease after allogeneic blood stem-cell transplantation.
|
|
Academic Article
|
Unique abnormalities of CD4(+) and CD8(+) central memory cells associated with chronic graft-versus-host disease improve after extracorporeal photopheresis.
|
|
Academic Article
|
Phase 2 clinical trial of rapamycin-resistant donor CD4+ Th2/Th1 (T-Rapa) cells after low-intensity allogeneic hematopoietic cell transplantation.
|
|
Academic Article
|
Function, adjustment, quality of life and symptoms (FAQS) in allogeneic hematopoietic stem cell transplantation (HSCT) survivors: a study protocol.
|
|
Academic Article
|
Donor lymphocyte infusion: beauty is in the eye of the beholder.
|
|
Academic Article
|
Phase I clinical trial of costimulated, IL-4 polarized donor CD4+ T cells as augmentation of allogeneic hematopoietic cell transplantation.
|
|
Academic Article
|
Changes in salivary proteome following allogeneic hematopoietic stem cell transplantation.
|
|
Academic Article
|
NCI First International Workshop on The Biology, Prevention and Treatment of Relapse after Allogeneic Hematopoietic Cell Transplantation: report from the committee on prevention of relapse following allogeneic cell transplantation for hematologic malignancies.
|
|
Academic Article
|
Association of serum interleukin-7 levels with the development of acute graft-versus-host disease.
|
|
Academic Article
|
Pseudoautologous blood stem cell transplantation for refractory chronic graft-versus-host disease.
|
|
Academic Article
|
Allogeneic hematopoietic cell transplantation for neuroblastoma: the CIBMTR experience.
|
|
Academic Article
|
Rapid complete donor lymphoid chimerism and graft-versus-leukemia effect are important in early control of chronic lymphocytic leukemia.
|
|
Academic Article
|
Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse After Hematopoietic Stem Cell Transplantation: part III. Prevention and treatment of relapse after allogeneic transplantation.
|
|
Academic Article
|
Ultra-short course sirolimus contributes to effective GVHD prophylaxis after reduced-intensity allogeneic hematopoietic cell transplantation.
|
|
Academic Article
|
Treatments of disease relapse after allogeneic stem cell transplantation focusing on donor lymphocyte infusion.
|
|
Academic Article
|
Emergencies related to cancer chemotherapy and hematopoietic stem cell transplantation.
|
|
Academic Article
|
Unrelated donor marrow transplantation for B-cell chronic lymphocytic leukemia after using myeloablative conditioning: results from the Center for International Blood and Marrow Transplant research.
|
|
Academic Article
|
Long-term survival in advanced chronic myelogenous leukemia following bone marrow transplantation from haploidentical related donors.
|
|
Academic Article
|
Immunological and clinical effects of post-transplant G-CSF versus placebo in T-cell replete allogeneic blood transplant patients: results from a randomized double-blind study.
|
|
Academic Article
|
Potential use of hematopoietic stem cells after radiation injury.
|
|
Academic Article
|
Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity?
|
|
Academic Article
|
Clinical "cytokine storm" as revealed by monocyte intracellular flow cytometry: correlation of tumor necrosis factor alpha with severe gut graft-versus-host disease.
|
|
Academic Article
|
Topical corticosteroid therapy for cicatricial conjunctivitis associated with chronic graft-versus-host disease.
|
|
Academic Article
|
Development of severe sclerotic chronic GVHD during treatment with dasatinib.
|
|
Academic Article
|
Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival.
|
|
Academic Article
|
Incidence and predictors of respiratory viral infections by multiplex PCR in allogeneic hematopoietic cell transplant recipients 50 years and older including geriatric assessment.
|
|
Academic Article
|
Reduced-Intensity Allogeneic Transplant for Acute Myeloid Leukemia and Myelodysplastic Syndrome Using Combined CD34-Selected Haploidentical Graft and a Single Umbilical Cord Unit Compared with Matched Unrelated Donor Stem Cells in Older Adults.
|
|
Academic Article
|
Combined Haploidentical and Umbilical Cord Blood Allogeneic Stem Cell Transplantation for High-Risk Lymphoma and Chronic Lymphoblastic Leukemia.
|
|
Academic Article
|
Haploidentical vs haplo-cord transplant in adults under 60 years receiving fludarabine and melphalan conditioning.
|
|
Academic Article
|
Dose escalation prophylactic donor lymphocyte infusion after T-cell depleted matched related donor allogeneic hematopoietic cell transplantation is feasible and results in higher donor chimerism, faster immune re-constitution, and prolonged progression-free survival.
|
|
Academic Article
|
Unexpected Toxicities When Nivolumab Was Given as Maintenance Therapy following Allogeneic Stem Cell Transplantation.
|
|
Academic Article
|
Allogeneic hematopoietic stem cell transplant outcomes in adults with inherited myeloid malignancies.
|